+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Somatostatin in the emergency treatment of persistent hypoglycemias caused by hyperinsulinism (nesidioblastosis of the pancreas)

Somatostatin in the emergency treatment of persistent hypoglycemias caused by hyperinsulinism (nesidioblastosis of the pancreas)

Monatsschrift Kinderheilkunde 133(8): 527-531

11 infants with persisting hypoglycemia due to hyperinsulinism (nesidioblastosis of the pancreas) were treated with somatostatin. Somatostatin administration in a relatively high dosage (initially 145 micrograms/m2 body surface as bolus followed by a continuous infusion of the same dose per hour) resulted in a suppression of the circulating insulin concentration leading to a less abrupt fall of the postprandial plasma glucose level. By somatostatin infusion we were able to keep two patients with intractable neonatal hypoglycemia in a normoglycemic state until subtotal pancreatectomy. Infants suffering from nesidioblastosis require 1.0-4.5 micrograms/kg/h somatostatin and a concomitant carbohydrate supply of 0.3-0.48 g/kg/h in order to maintain normoglycemia. An initial somatostatin bolus can be omitted. Somatostatin is very reliable in the treatment of neonatal hypoglycemia due to hyperinsulinism for a limited period of time until subtotal pancreatectomy is performed. In most cases of nesidioblastosis this operative measure seems to be inevitable for the control of hyperinsulinism.

Please choose payment method:

(PDF emailed within 1 workday: $29.90)

Accession: 041393591

Download citation: RISBibTeXText

PMID: 2864633

Related references

Nesidioblastosis--a rare cause of persistent congenital hypoglycemias. Kinderarztliche Praxis 53(6): 291-295, 1985

Somatostatin in a case of neonatal hyperinsulinism caused by focal adenomatosis of the head of pancreas. Archives Francaises de Pediatrie 44(9): 803-805, 1987

Nesidioblastosis and persistent neonatal hyperinsulinism. Journees Annuelles de Diabetologie de L'hotel-Dieu: 73-82, 1995

Somatostatin analogue SMS 201-995 in the short-term management of neonatal hyperinsulinism due to nesidioblastosis. Australian Paediatric Journal 24(6): 375-378, 1988

Long term treatment with a somatostatin analogue sms 201 995 in a patient with persistent hypoglycemia due to nesidioblastosis. Pediatric Research 20(11): 1184, 1986

Nesidioblastosis and adenomatosis of the pancreas as rare causes of organic hyperinsulinism. Chirurg 63(2): 139-142, 1992

Nesidioblastosis and adenomatosis of the pancreas as an unusual cause of organic hyperinsulinism. Der Chirurg; Zeitschrift für Alle Gebiete der Operativen Medizen 63(2): 139-142, 1992

Familial hyperinsulinism with nesidioblastosis of the pancreas: further evidence for autosomal recessive inheritance. American Journal of Medical Genetics 34(4): 584-586, 1989

Neonatal hypoglycemia caused by hyperinsulinism and nesidioblastosis. Revista Chilena de Pediatria 58(4): 291-296, 1987

Immunohistochemical, morphometric, and clinical studies of the pancreatic islets in infants with persistent neonatal hypoglycemia of familial type with hyperinsulinism and nesidioblastosis. Acta Biologica et Medica Germanica 40(1): 39-54, 1981

Persistent neonatal hypoglycemia in nesidioblastosis of the pancreas. Padiatrie und Padologie 25(1): 25-31, 1990

Nesidioblastosis of the pancreas in an adult with persistent hyperinsulinemic hypoglycemia. American Journal of Clinical Pathology 91(3): 336-340, 1989

Differential diagnosis by biochemical tests of hypoglycemias caused by functional disorder or adenoma of the pancreas. Vie Medicale 36(10): 1083-1089, 1955

Growth in a girl with nesidioblastosis during and after treatment with the somatostatin analogue sms 201 995. Pediatric Research 24(4): 534, 1988

Hyperinsulinism caused by diffuse adenomatosis of the pancreas. Pathologica 54: 39-50, 1962